Literature DB >> 20368286

Metabolic shifts in immunity and inflammation.

Douglas J Kominsky1, Eric L Campbell, Sean P Colgan.   

Abstract

Sites of ongoing inflammation and triggered immune responses are characterized by significant changes in metabolic activity. Recent studies have indicated that such shifts in tissue metabolism result from a combination of profound recruitment of inflammatory cells (neutrophils and monocytes) and high proliferation rates among lymphocyte populations. The resultant shifts in energy supply and demand can result in metabolic acidosis and diminished delivery and/or availability of oxygen, leading to hypoxia extensive enough to trigger transcriptional and translation changes in tissue phenotype. Such phenotypic shifts can imprint fundamental changes to tissue metabolism. In this study, we review recent work addressing metabolic changes and metabolic control of inflammation and immunity.

Entities:  

Mesh:

Year:  2010        PMID: 20368286      PMCID: PMC4077461          DOI: 10.4049/jimmunol.0903002

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  95 in total

Review 1.  Epigenetic reprogramming in mammals.

Authors:  Hugh D Morgan; Fátima Santos; Kelly Green; Wendy Dean; Wolf Reik
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

Review 2.  Fuel feeds function: energy metabolism and the T-cell response.

Authors:  Casey J Fox; Peter S Hammerman; Craig B Thompson
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation.

Authors:  Joseph Khoury; Juan C Ibla; Andrew S Neish; Sean P Colgan
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

Review 6.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

Review 7.  Hypoxia and gastrointestinal disease.

Authors:  Cormac T Taylor; Sean P Colgan
Journal:  J Mol Med (Berl)       Date:  2007-11-20       Impact factor: 4.599

8.  Alteration of PTGS2 promoter methylation in chronic periodontitis.

Authors:  S Zhang; S P Barros; M D Niculescu; A J Moretti; J S Preisser; S Offenbacher
Journal:  J Dent Res       Date:  2009-12-30       Impact factor: 6.116

9.  Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.

Authors:  Steffen E Schnitzer; Andreas Weigert; Jie Zhou; Bernhard Brüne
Journal:  Mol Cancer Res       Date:  2009-02-24       Impact factor: 5.852

10.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

View more
  159 in total

1.  An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling.

Authors:  Douglas J Kominsky; Simon Keely; Christopher F MacManus; Louise E Glover; Melanie Scully; Colm B Collins; Brittelle E Bowers; Eric L Campbell; Sean P Colgan
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 2.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

3.  IFN-γ attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1β.

Authors:  Louise E Glover; Karina Irizarry; Melanie Scully; Eric L Campbell; Brittelle E Bowers; Carol M Aherne; Douglas J Kominsky; Christopher F MacManus; Sean P Colgan
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

Review 4.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

5.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

6.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

7.  HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function.

Authors:  Thomas Weissmüller; Louise E Glover; Blair Fennimore; Valerie F Curtis; Christopher F MacManus; Stefan F Ehrentraut; Eric L Campbell; Melanie Scully; Bryon D Grove; Sean P Colgan
Journal:  FASEB J       Date:  2013-09-12       Impact factor: 5.191

8.  Metabolic regulation of intestinal epithelial barrier during inflammation.

Authors:  Sean P Colgan; Valerie F Curtis; Jordi M Lanis; Louise E Glover
Journal:  Tissue Barriers       Date:  2015-04-03

Review 9.  The bioenergetics of inflammation: insights into obesity and type 2 diabetes.

Authors:  K N Keane; E K Calton; R Carlessi; P H Hart; P Newsholme
Journal:  Eur J Clin Nutr       Date:  2017-04-12       Impact factor: 4.016

Review 10.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.